Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

Go back to Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

InvenTrust Properties Corp. Reports 2024 Third Quarter Results

October 29, 2024 4:10 PM EDT

DOWNERS GROVE, Ill.--(BUSINESS WIRE)-- InvenTrust Properties Corp. (InvenTrust or the Company) (NYSE: IVT) today reported financial and operating results for the period ended September 30, 2024. For the three months ended September 30, 2024 and 2023, the Company reported Net Loss of $0.5 million, or $0.01 per diluted share, and Net Loss of $0.8 million, or $0.01 per diluted share, respectively.

Third Quarter 2024 Highlights:

Nareit FFO of $0.45 per diluted share Core FFO of $0.44 per diluted share Same Property Net Operating Income (NOI) growth of 6.5% Leased Occupancy as of... More